Literature DB >> 6305653

Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.

R Salvayre, A Maret, A Negre, G Lenoir, M Vuillaume, J Icart, J Didier, L Douste-Blazy.   

Abstract

In whole leukocytes and in lymphocytes from normal subjects, the percentage activity of heat-stable beta-N-acetylhexosaminidase (30 +/- 5% and 45 +/- 5%, respectively) was higher than in the transformed lymphoid cell line (19 +/- 3%). In Tay-Sachs transformed cells as well as non-transformed beta-N-acetylhexosaminidase was almost completely heat-stable (95 - 98%). In the transformed cells from normal subjects, the beta-N-acetylhexosaminidase B (Hex B) activity (5% of total) was significantly lower than in blood lymphocytes (average 25 - 30% of total activity), whereas Hex A and Hex I were similar in the either cell type. Blood lymphocytes and lymphoid cell lines established from a Tay-Sachs patient lacked heat-labile Hex A and expressed high heat-stable Hex I and Hex B activities (3-6-fold). After neuraminidase treatment, Hex A peak sharpened while Hex I peaks switched to higher pI than normal Hex I, in the region of Hex B. PreHex A/S pI was not affected. Hydrolytic properties using the both substrates (4-methylumbelliferyl-2-acetamido-2-deoxy-beta-D-glucopyranoside and 4-methylumbelliferyl-2-acetamido-2-deoxy-beta-D-galactopyranoside) of each molecular form were similar in transformed and non-transformed cells. Data derived from the use of a mixture of substrates were consistent with the model which proposes a common active site for either substrate in the case of preHex A, Hex B and Hex I, but not for Hex A. Thus Epstein-Barr virus-transformed lymphoid cell lines represent an accurate model system for studies on Tay-Sachs disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305653     DOI: 10.1111/j.1432-1033.1983.tb07509.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Lymphoid cell lines as a model system for the study of Wolman's disease: enzymatic, metabolic and ultrastructural investigations.

Authors:  A Nègre; R Salvayre; A Maret; C Vieu; J C Bes; C Borrone; P Durand; L Douste-Blazy
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects.

Authors:  J Radom; R Salvayre; T Levade; L Douste-Blazy
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

3.  Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain.

Authors:  L M Hoffman; S E Brooks; M R Stein; M Adachi; L Schneck
Journal:  Metab Brain Dis       Date:  1989-06       Impact factor: 3.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.